Zacks Investment Research on MSN
Q32 Bio (QTTB) upgraded to strong buy: Here's what you should know
Q32 Bio (QTTB) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...
Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, ...
Zacks.com on MSN
Wall Street Analysts See a 103.55% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High?
Shares of Q32 Bio (QTTB) have gained 83.8% over the past four weeks to close the last trading session at $7.04, but there could still be a solid upside left in the stock if short-term price targets of ...
Bio-Techne develops specialized reagents and diagnostic solutions for global research and clinical markets in the life sciences sector.
The average one-year price target for GRI Bio (NasdaqCM:GRI) has been revised to $656.88 / share. This is an increase of 2,700.00% from the prior estimate of $23.46 dated January 11, 2026. The price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results